×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
RCEL – avita medical, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
RCEL
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/12
04:12 pm
rcel
AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand [Yahoo! Finance]
Low
Report
AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand [Yahoo! Finance]
11/12
04:03 pm
rcel
AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand
Low
Report
AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand
11/9
08:22 am
rcel
AVITA Medical, Inc. (NASDAQ:RCEL) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year [Yahoo! Finance]
Low
Report
AVITA Medical, Inc. (NASDAQ:RCEL) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year [Yahoo! Finance]
11/8
09:12 am
rcel
AVITA Medical, Inc. (NASDAQ: RCEL) had its "neutral" rating re-affirmed by analysts at Piper Sandler. They now have a $12.00 price target on the stock, up previously from $9.00.
Low
Report
AVITA Medical, Inc. (NASDAQ: RCEL) had its "neutral" rating re-affirmed by analysts at Piper Sandler. They now have a $12.00 price target on the stock, up previously from $9.00.
11/8
09:00 am
rcel
AVITA Medical to Host Investor Webinar Briefing
Medium
Report
AVITA Medical to Host Investor Webinar Briefing
11/7
04:18 pm
rcel
AVITA Medical Reports Third Quarter Financial Results [Yahoo! Finance]
High
Report
AVITA Medical Reports Third Quarter Financial Results [Yahoo! Finance]
11/7
04:03 pm
rcel
AVITA Medical Reports Third Quarter Financial Results
Low
Report
AVITA Medical Reports Third Quarter Financial Results
10/10
05:19 pm
rcel
AVITA Medical to Announce Third Quarter 2024 Financial Results [Yahoo! Finance]
Medium
Report
AVITA Medical to Announce Third Quarter 2024 Financial Results [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/7
04:12 pm
rcel
Form 10-Q AVITA Medical, Inc. For: Sep 30
Medium
Report
Form 10-Q AVITA Medical, Inc. For: Sep 30
11/7
04:06 pm
rcel
Form 8-K AVITA Medical, Inc. For: Nov 07
Low
Report
Form 8-K AVITA Medical, Inc. For: Nov 07
8/20
04:30 pm
rcel
Form 4 AVITA Medical, Inc. For: Aug 19 Filed by: McNamara Robert
Medium
Report
Form 4 AVITA Medical, Inc. For: Aug 19 Filed by: McNamara Robert
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
4/6
AVITA MED LTD/S ADR (NASDAQ: RCEL) had its "buy" rating re-affirmed by analysts at BTIG Research. They now have a $8.00 price target on the stock.
12.2%
2/9 Did The Underlying Business Drive Avita Medical's (ASX:AVH) Lovely 730% Share Price Gain? [Yahoo! Finance News] 7.4%
3/3 AVITA Medical to Attend the 2020 BTIG Healthcare Conference 4.3%
1/29 AVITA MED LTD/S ADR (NASDAQ: RCEL) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 4.3%
4/25 AVITA MED LTD/S ADR (NASDAQ: RCEL) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $6.25 price target on the stock. 3.1%
10/30 AVITA Medical Reports First Quarter Fiscal 2020 Financial Results and Company Update 2.7%
12/29 AVITA Medical Receives U.S. FDA Investigational Device Exemption Approval of Clinical Feasibility Study to Evaluate RECELL System for Vitiligo 2.1%
12/6 Australia shares advance despite trade talk angst; NZ inches higher [Reuters] 1.8%
4/1 RECELL® System Data Accepted to 52nd Annual American Burn Association Meeting Available Online 1.8%
2/3 Form 6-K Avita Medical, Ltd. For: Feb 03 1.2%
2/9 Did The Underlying Business Drive Avita Medical's (ASX:AVH) Lovely 730% Share Price Gain? [Yahoo! Finance News] 7.4%
3/3 AVITA Medical to Attend the 2020 BTIG Healthcare Conference 4.3%
1/29 AVITA MED LTD/S ADR (NASDAQ: RCEL) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 4.3%
4/25 AVITA MED LTD/S ADR (NASDAQ: RCEL) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $6.25 price target on the stock. 3.1%
10/30 AVITA Medical Reports First Quarter Fiscal 2020 Financial Results and Company Update 2.7%
12/29 AVITA Medical Receives U.S. FDA Investigational Device Exemption Approval of Clinical Feasibility Study to Evaluate RECELL System for Vitiligo 2.1%
12/6 Australia shares advance despite trade talk angst; NZ inches higher [Reuters] 1.8%
4/1 RECELL® System Data Accepted to 52nd Annual American Burn Association Meeting Available Online 1.8%
2/3 Form 6-K Avita Medical, Ltd. For: Feb 03 1.2%
TOP News Decliners
3/17
AVITA MED LTD/S ADR (NASDAQ: RCEL) was downgraded by analysts at ValuEngine from a "sell" rating to a "strong sell" rating.
-19.2%
11/13 Form 6-K Avita Medical, Ltd. For: Nov 13 -10.1%
4/20 AVITA MED LTD/S ADR (NASDAQ: RCEL) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating on the stock. -10.0%
3/4 Avita Medical launches pivotal study of Recell in kids [Seeking Alpha] -7.6%
11/19 Form 20-F/A Avita Medical, Ltd. For: Jun 30 -7.6%
2/19 Form 6-K Avita Medical, Ltd. For: Feb 18 -7.2%
4/15 Form 6-K Avita Medical, Ltd. For: Apr 06 -5.6%
1/31 Australia, NZ shares helped by China PMI; virus anxiety caps gains [Reuters] -5.4%
3/6 AVITA MED LTD/S ADR (NASDAQ: RCEL) had its "buy" rating re-affirmed by analysts at Lake Street Capital. They now have a $12.00 price target on the stock. -5.1%
11/12 AVITA Medical Announces Institutional Placement of A$120.0 Million to Support Commercial Growth and Pipeline Development -4.2%
11/13 Form 6-K Avita Medical, Ltd. For: Nov 13 -10.1%
4/20 AVITA MED LTD/S ADR (NASDAQ: RCEL) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating on the stock. -10.0%
3/4 Avita Medical launches pivotal study of Recell in kids [Seeking Alpha] -7.6%
11/19 Form 20-F/A Avita Medical, Ltd. For: Jun 30 -7.6%
2/19 Form 6-K Avita Medical, Ltd. For: Feb 18 -7.2%
4/15 Form 6-K Avita Medical, Ltd. For: Apr 06 -5.6%
1/31 Australia, NZ shares helped by China PMI; virus anxiety caps gains [Reuters] -5.4%
3/6 AVITA MED LTD/S ADR (NASDAQ: RCEL) had its "buy" rating re-affirmed by analysts at Lake Street Capital. They now have a $12.00 price target on the stock. -5.1%
11/12 AVITA Medical Announces Institutional Placement of A$120.0 Million to Support Commercial Growth and Pipeline Development -4.2%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: